Post ERCP Pancreatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults aged >18 and <85 years, of any gender. 2. Normal serum amylase levels before ERCP. 3. Willingness to comply with study procedures and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Individuals with severe cardiovascular, renal, or hepatic diseases, such as severe cardiopulmonary or renal insufficiency;2. Pregnant or breastfeeding women;3. Individuals allergic to contrast agents;4. Individuals with pancreatic diseases such as acute pancreatitis, acute exacerbation of chronic pancreatitis, chronic pancreatitis, pancreatic duct dilation, or pancreatic cancer;5. Individuals with active gastrointestinal function;6. Individuals with mental disorders or diseases, partial or complete impairment of consciousness or behavioral abilities, lacking the capacity for independent decision-making;7. Individuals currently participating in other clinical trials or who have participated in other clinical trials within the last 60 days;8. Individuals who refuse to sign the informed consent form;9. Cases deemed unsuitable by the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amylase 3 hours after ERCP;Amylase 24 hours after ERCP; | — |
Secondary
| Measure | Time frame |
|---|---|
| white blood cell;Aspartate aminotransferase;Alanine aminotransferase;Total bilirubin;C-reactive protein;Procalcitonin;IL-6;IL-8;IL-10;TNF-a; | — |
Countries
China
Contacts
The First Affiliated Hospital of Nanchang University